Cibus (CBUS) Invested Capital (2016 - 2026)
Cibus (CBUS) posted Invested Capital of $435000.0 for Q4 2025, down 34.29% sequentially from $662000.0 in Q3 2025, and up 284.96% YoY from $113000.0 in Q4 2024.
Cibus (CBUS) Invested Capital (2016 - 2026) Analysis & Trends
Cibus has reported Invested Capital for 10 years, with the latest figure at $435000.0 in Q4 2025.
- Quarterly Invested Capital rose 284.96% year-over-year to $435000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 86.55% YoY) and the FY2025 annual result came in at $435000.0, up 284.96% from the prior year.
- Invested Capital declined to $435000.0 in Q4 2025 per CBUS's latest filing, from $662000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $662000.0 in Q3 2025 and troughed at $97000.0 in Q4 2022.
- A 5-year average of $222368.4 and a median of $164000.0 in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2021 and 2025: Invested Capital tumbled 79.42% in 2021, then surged 501.82% in 2025.
- Over 5 years, Invested Capital stood at $172000.0 in 2021, then sank by 43.6% to $97000.0 in 2022, then jumped by 209.28% to $300000.0 in 2023, then tumbled by 62.33% to $113000.0 in 2024, then jumped by 284.96% to $435000.0 in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $435000.0, $662000.0, and $119000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | 812,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 812,000.00 |
| Dec 31, 2025 | 435,000.00 |
| Sep 30, 2025 | 662,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | 110,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 337,000.00 |
| Jun 30, 2023 | 164,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | 120,000.00 |
| Jun 30, 2022 | 283,000.00 |
| Mar 31, 2022 | 315,000.00 |
| Dec 31, 2021 | 172,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 114,000.00 |